Related Experiment Video
Updated: Aug 5, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Longitudinal Outcomes of Mitral Valve Surgery for Infective Endocarditis Within a Repair-First Strategy
Hakam Rajjoub1, Stanley B Wolfe1, Lawrence Wei1
1Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, West Virginia.
Background:
Mitral valve (MV) infective endocarditis (IE) often necessitates surgical intervention for severe mitral regurgitation, yet the longitudinal impact of MV surgery within a repair-first strategy remains unclear.
Methods:
An institutional multidisciplinary endocarditis database incorporating The Society of Thoracic Surgeons data identified patients undergoing MV surgery for acute IE between July 2016 and June 2024. Cases were managed with a repair-first operative strategy, with MV replacement reserved for patients in whom repair was not feasible. Primary outcomes were survival and the composite of reinfection, reoperation, or death. Secondary measures included perioperative outcomes and the individual components of the composite.
Results:
A total of 198 patients underwent first-time MV intervention for IE (repair, 102 [51.5%]) or replacement, 96 [48.5%]). The repair group was younger (45 vs 51 years; P = .03) and had fewer prior non-MV cardiac surgeries (18.6% vs 34.4%; P = .01). The repair group had less prolonged ventilation (14.7% vs 32.3%; P = .003) and shorter intensive care unit stay (73 vs 121 hours; P < .0001). MV repair was associated with superior risk-adjusted survival (hazard ratio, 0.49; P = .01) and freedom from the composite outcome of reoperation, reinfection, or death (hazard ratio, 0.27; P < .001).
Conclusions:
Complex MV repair (defined as leaflet modification or patch reconstruction) in acute IE is safe and durable. Within a repair-first strategy, successful repair was associated with favorable perioperative recovery and improved midterm outcomes. These findings support a repair-first approach when it is anatomically and technically feasible.
Insights
Mitral valve repair in infective endocarditis offers better survival and fewer complications than replacement. A repair-first strategy is safe and effective for improving patient outcomes.
Area of Science:
- Cardiovascular Surgery
- Infective Endocarditis
- Mitral Valve Disease
Background:
- Mitral valve (MV) infective endocarditis (IE) often requires surgery for severe mitral regurgitation.
- The long-term effects of MV surgery using a repair-first approach are not well understood.
Purpose of the Study:
- To evaluate the outcomes of mitral valve surgery in patients with acute infective endocarditis.
- To compare the results of mitral valve repair versus replacement within a repair-first strategy.
Main Methods:
- A retrospective analysis of 198 patients undergoing MV surgery for IE between 2016 and 2024.
- Patients were managed with a repair-first strategy; replacement was used when repair was not feasible.
- Primary outcomes included survival and a composite of reinfection, reoperation, or death.
Main Results:
- 102 patients (51.5%) underwent repair and 96 (48.5%) underwent replacement.
- The repair group had significantly better survival (HR 0.49, p=0.01) and freedom from composite outcomes (HR 0.27, p<0.0001).
- Repair was associated with shorter ICU stays and less prolonged ventilation.
Conclusions:
- Complex mitral valve repair in acute IE is safe and durable.
- A repair-first strategy leads to favorable perioperative recovery and improved mid-term outcomes.
- These findings support a repair-first approach for MV intervention in IE when feasible.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Valve Prolapse II: Assessment and Management

